홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /화합물

스테아린산 납

Lead stearate

HCID 61258
새 노트새 반응견적 요청하기
인쇄 미리보기

데이터를 보충하는 중입니다. 잠시 후 페이지를 새로 고치면 최신 내용을 볼 수 있습니다

기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
1072-35-1
표준 SMILES
CCCCCCCCCCCCCCCCCC(=O)[O-].CCCCCCCCCCCCCCCCCC(=O)[O-].[Pb+2]
InChIKey
UQLDLKMNUJERMK-UHFFFAOYSA-L
분자식
Pb(C18H35O2)2
평균 분자량
774 g/mol
단동위원소 질량
774.50406282

개요

Powdery white solid with a slight fatty odor. Sinks in water. (USCG, 1999)

이름 및 식별자

우선 이름
Lead stearate
IUPAC
lead(2+);bis(octadecanoate)
현지명
스테아린산 납
영어명
LEAD STEARATE
분자식
C36H70O4Pb
분자량
774.14

이름 및 동의어

LEAD STEARATE1072-35-1Lead distearateLead(II) stearateStabinex NC18Listab 28NDLead(2+) stearateLead (II) stearateLead(II) octadecaoateOctadecanoic acid, lead(2+) saltLead(2+) octadecanoateSL 1000 (stabilizer)
이름 더 보기
스테아린산납스테아르산납스테아린산납다이스테아르산납다이스테아르산 납스테아르산 납스테아르산 납(2+)스테아르산 납(II)스테아르산, 납 (2+) 염옥타데칸산 납(2+)옥타데칸산 납(II)옥타데칸산, 납(2+) 염옥타데칸산, 납(2+) 염 (2:1)LSLP-51P-289Haro chem P28GLead(Ⅱ)StearateLEAD(+2)STEARATEplumbous stearate
Lead distearate, pureStearic acid, lead(2+) saltHQ5TZ3NAEI5002GEINECS 214-005-2Octadecanoic acid, lead(2+) salt, basicOctadecanoic acid, lead(2+) salt (2:1)Lead(II) octadecanoate

데이터베이스 식별자

CAS
1072-35-1、7428-48-0、90459-52-2
PubChem CID
61258
DTXSID
DTXSID0029630
UNII
HQ5TZ3NAEI
EC Number
214-005-2、291-696-7
Nikkaji
J43.179F

물성

구조 계산 물성보충 중

극성 표면적
80.3 Ų
수소 결합 공여자 수
0
수소 결합 수용자 수
4
회전 가능 결합 수
30
무거운 원자 수
41
형식 전하
0
복잡도
196

실험 및 물리화학적 성질

Chemical Classes · 2건

Metals -> Organic Acids, Metal Salts

Carcinogens

Density1.34 to 1.4 (USCG, 1999)
Flash Point · 2건

greater than 450 °F (USCG, 1999)

Flash point > 450 °F

Melting Point240.3 °F (USCG, 1999)
Physical Description · 2건

Powdery white solid with a slight fatty odor. Sinks in water. (USCG, 1999)

White solid with slight fatty odor; [CAMEO]

물리화학적 성질

녹는점
105 · 105~112℃
밀도
1.323 · 1.323
저장 조건
Inert atmosphere,Room Temperature
용해도
2 O; · insoluble in H2O; soluble in hot ethanol
물리적 상태
가루
색상
하얀색
수용성
뜨거운 알코올에 용해됩니다. 따뜻한 물에 약간 용해됩니다.
EPA
Lead(II) stearate (1072-35-1)

화학적 성질

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 6건

Danger

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P203, P260, P261, P264, P270, P271, P273, P280, P301+P317, P304+P340, P317, P318, P319, P330, P391, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 117 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Danger

H351: Suspected of causing cancer [Warning Carcinogenicity]

유해성 정보

Regulatory Information · 6건

Chemical: Octadecanoic acid, lead(2+) salt

Chemical: Octadecanoic acid, lead salt

Restricted substance: Lead distearate

Restricted substance: Octadecanoic acid, lead(2+) salt, basic

Octadecanoic acid, lead(II) salt: Does not have an individual approval but may be used under an appropriate group standard

Octadecanoic acid, lead salt: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.

Other Safety Information · 2건

IMAP assessments - 1:2 Lead(2+) salts of long-chain carboxylic acids: Environment tier II assessment

IMAP assessments - Lead Salts of Selected Fatty Acids: Human health tier II assessment

DOT LabelPoison
Fire HazardsSpecial Hazards of Combustion Products: At high temperature toxic fumes are emitted.
Health Hazards · 1건

INHALATION: Joint and muscle pains, headache, dizziness, and insomnia. Weakness, frequently of extensor muscles of hand and wrist (unilateral or bilateral). Heavy contamination - brain damage. Stupor progressing to coma - with or without convulsion, often death. Excitation, confusion and mania less common. Cerebrospinal pressure may be increased. INGESTION: Abdominal pain, diarrhea, constipation, loss of appetite, muscular weakness, headache, blue line on gums, metallic taste, nausea, and vomiting. (USCG, 1999)

화학 및 산업

약리 정보

Metabolism/Metabolites · 1건

Lead is absorbed following inhalation, oral, and dermal exposure. It is then distributed mainly to the bones and red blood cells. In the blood lead may be found bound to serum albumin or the metal-binding protein metallothionein. Organic lead is metabolized by cytochrome P-450 enzymes, whereas inorganic lead forms complexes with delta-aminolevulinic acid dehydratase. Lead is excreted mainly in the urine and faeces. (L136)

용도 및 제조

UsesUsed in high-pressure lubricants and varnish driers; [Merck Index]
General Manufacturing InformationOctadecanoic acid, lead(2+) salt (2:1): ACTIVE

응용 분야

용도In extreme pressure lubricants; as drier in varnishes.

상·하류 제품 정보

상류 원료

납 테트라아세트산질산납스테아르산초산납염산질산수산화나트륨납

하류 제품

emulsion waterproof agent

관련 반응

5건
반응 기록 만들기
HRID 615478 반응식
HRID 615478촉매로uspto-grants-1985_02
HRID 1065200 반응식
HRID 1065200생성물로uspto-grants-1982_05
HRID 1074626 반응식
HRID 1074626촉매로uspto-grants-1983_07
HRID 1651012 반응식
HRID 1651012생성물로uspto-grants-1990_05
HRID 2285695 반응식
HRID 2285695생성물로uspto-grants-1982_04

화합물 노트

불러오는 중…

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
더보기
새 노트새 반응견적 요청하기

Lead stearate is an organic lead compound. It is a white powder with a slight fatty odor.

Hazards SummarySee Lead and linked occupational diseases.
Reactive GroupHydrocarbons, Aliphatic Saturated
Reactivity Profile · 1건

LEAD STEARATE has weak oxidizing or reducing powers. Redox reactions can however still occur. The majority of compounds in this class are slightly soluble or insoluble in water. If soluble in water, then the solutions are usually neither strongly acidic nor strongly basic. These compounds are not water-reactive.

Air and Water ReactionsInsoluble in water.
Hazard Classes and Categories · 6건

Acute Tox. 4 (100%)

Acute toxicity - category 4

Acute toxicity - category 4

Carcinogenicity - Category 1B

Carcinogenicity - Category 2

Carcinogens

안전 및 보호

Fire FightingFire Extinguishing Agents: Chemical, foam, CO2, water (fog) (USCG, 1999)
First AidCall a physician.
Exposure Control and Personal ProtectionBiological Exposure Indices (BEI) [ACGIH] - Lead in blood = 200 ug/L (20 ug/100 ml); sampling time not critical; [ACGIH]
Nonfire Spill ResponseExcerpt from ERG Guide 151 [Substances - Toxic (Non-Combustible)]:
Isolation and EvacuationExcerpt from ERG Guide 151 [Substances - Toxic (Non-Combustible)]:
Minimum Risk LevelChronic Inhalation: 0.05 mg/m3 (L134)
Threshold Limit Values (TLV)0.05 [mg/m3], as Pb
Permissible Exposure Limit (PEL)0.05 [mg/m3], as Pb
Personal Protective Equipment (PPE)Dust and/or fume respirator, gloves, goggles or safety glasses, coveralls, and cap. (USCG, 1999)

독성 정보

TreatmentLead poisoning is usually treated with chelation therapy using DMSA, EDTA, or dimercaprol. (L21)
Health Effects · 1건

Lead is a neurotoxin and has been known to cause brain damage and reduced cognitive capacity, especially in children. Lead exposure can result in nephropathy, as well as blood disorders such as high blood pressure and anemia. Lead also exhibits reproductive toxicity and can results in miscarriages and reduced sperm production. (L21)

Adverse EffectsNeurotoxin - Predominantly motor
Exposure RoutesOral (L136) ; inhalation (L136) ; dermal (L136)
Toxicity Summary · 1건

Lead mimics other biologically important metals, such as zinc, calcium, and iron, competing as cofactors for many of their respective enzymatic reactions. For example, lead has been shown to competitively inhibit calcium's binding of calmodulin, interferring with neurotransmitter release. It exhibits similar competitive inhibition at the NMDA receptor and protein kinase C, which impairs brain microvascular formation and function, as well as alters the blood-brain barrier. Lead also affects the nervous system by impairing regulation of dopamine synthesis and blocking evoked release of acetylcholine. However, it's main mechanism of action occurs by inhibiting delta-aminolevulinic acid dehydratase, an enzyme vital in the biosynthesis of heme, which is a necesssary cofactor of hemoglobin. (T4, A20, A22, L136)

Signs and Symptoms · 1건

Symptions of chronic lead poisoning include reduced cognitive abilities, nausea, abdominal pain, irritability, insomnia, metal taste in the mouth, excess lethargy or hyperactivity, chest pain, headache and, in extreme cases, seizures, comas, and death. There are also associated gastrointestinal problems, such as constipation, diarrhea, vomiting, poor appetite, weight loss, which are common in acute poisoning. (A2, L21)

Carcinogen Classification · 1건

Organic lead compounds are not classifiable as to their carcinogenicity to humans (Group 3). To the extent that organic lead compounds are metabolized in part to ionic lead, they are expected to exert the toxicities associated with inorganic lead (Group 2A, probably carcinogenic to humans). (L135)

안전 데이터

tsca
TSCA listed
ridadr
2291
risk_code
20/22-33-50/53-61-62
safety_code
45-53
위험 등급
6.1
기존화학 물질
KE-26388
함량 및 규제정보
물질구분: 유독물질; 혼합물(제품)함량정보: 사산화납(lead tetraoxide), 황산납(lead sulfate), 염기성탄산납(basic lead carbonate)을 제외한 납화합물(Lead compounds) 및 이를 25% 이상 함유한 혼합물. 다만, 초산납(lead acetate), 알킬화납(lead alkyls), 아지드화납(lead azide), 이초산납(lead di(acetate)), 메탄술폰산납(lead(Ⅲ) methansulfonate), 인산납(lead phosphate(3:2)), 스티핀산납(lead styphate)의 경우는 이를 0.5% 이상 함유한 혼합물
유해화학물질 필터링
97-1-9
중점관리물질 필터링
별표1-94